Medulloblastoma growth inhibition by Hedgehog pathway blockade

David M. Berman, Sunil S. Karhadkar, Andrew R. Hallahan, Joel I. Pritchard, Charles G Eberhart, D. Neil Watkins, James K. Chen, Michael K. Cooper, Jussi Taipale, James M. Olson, Philip A. Beachy

Research output: Contribution to journalArticle

Abstract

Constitutive Hedgehog (Hh) pathway activity is associated with initiation of neoplasia, but its role in the continued growth of established tumors is unclear. Here, we investigate the therapeutic efficacy of the Hh pathway antagonist cyclopamine in preclinical models of medulloblastoma, the most common malignant brain tumor in children. Cyclopamine treatment of murine medulloblastoma cells blocked proliferation in vitro and induced changes in gene expression consistent with initiation of neuronal differentiation and loss of neuronal stem cell-like character. This compound also caused regression of murine tumor allografts in vivo and induced rapid death of cells from freshly resected human medulloblastomas, but not from other brain tumors, thus establishing a specific role for Hh pathway activity in medulloblastoma growth.

Original languageEnglish (US)
Pages (from-to)1559-1561
Number of pages3
JournalScience
Volume297
Issue number5586
DOIs
StatePublished - Aug 30 2002
Externally publishedYes

Fingerprint

Medulloblastoma
Growth
Brain Neoplasms
Neoplasms
Allografts
Cell Death
Stem Cells
Cell Proliferation
Gene Expression
Therapeutics
cyclopamine

ASJC Scopus subject areas

  • General

Cite this

Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., ... Beachy, P. A. (2002). Medulloblastoma growth inhibition by Hedgehog pathway blockade. Science, 297(5586), 1559-1561. https://doi.org/10.1126/science.1073733

Medulloblastoma growth inhibition by Hedgehog pathway blockade. / Berman, David M.; Karhadkar, Sunil S.; Hallahan, Andrew R.; Pritchard, Joel I.; Eberhart, Charles G; Watkins, D. Neil; Chen, James K.; Cooper, Michael K.; Taipale, Jussi; Olson, James M.; Beachy, Philip A.

In: Science, Vol. 297, No. 5586, 30.08.2002, p. 1559-1561.

Research output: Contribution to journalArticle

Berman, DM, Karhadkar, SS, Hallahan, AR, Pritchard, JI, Eberhart, CG, Watkins, DN, Chen, JK, Cooper, MK, Taipale, J, Olson, JM & Beachy, PA 2002, 'Medulloblastoma growth inhibition by Hedgehog pathway blockade', Science, vol. 297, no. 5586, pp. 1559-1561. https://doi.org/10.1126/science.1073733
Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN et al. Medulloblastoma growth inhibition by Hedgehog pathway blockade. Science. 2002 Aug 30;297(5586):1559-1561. https://doi.org/10.1126/science.1073733
Berman, David M. ; Karhadkar, Sunil S. ; Hallahan, Andrew R. ; Pritchard, Joel I. ; Eberhart, Charles G ; Watkins, D. Neil ; Chen, James K. ; Cooper, Michael K. ; Taipale, Jussi ; Olson, James M. ; Beachy, Philip A. / Medulloblastoma growth inhibition by Hedgehog pathway blockade. In: Science. 2002 ; Vol. 297, No. 5586. pp. 1559-1561.
@article{5b80234093ee4508ba796865546f1670,
title = "Medulloblastoma growth inhibition by Hedgehog pathway blockade",
abstract = "Constitutive Hedgehog (Hh) pathway activity is associated with initiation of neoplasia, but its role in the continued growth of established tumors is unclear. Here, we investigate the therapeutic efficacy of the Hh pathway antagonist cyclopamine in preclinical models of medulloblastoma, the most common malignant brain tumor in children. Cyclopamine treatment of murine medulloblastoma cells blocked proliferation in vitro and induced changes in gene expression consistent with initiation of neuronal differentiation and loss of neuronal stem cell-like character. This compound also caused regression of murine tumor allografts in vivo and induced rapid death of cells from freshly resected human medulloblastomas, but not from other brain tumors, thus establishing a specific role for Hh pathway activity in medulloblastoma growth.",
author = "Berman, {David M.} and Karhadkar, {Sunil S.} and Hallahan, {Andrew R.} and Pritchard, {Joel I.} and Eberhart, {Charles G} and Watkins, {D. Neil} and Chen, {James K.} and Cooper, {Michael K.} and Jussi Taipale and Olson, {James M.} and Beachy, {Philip A.}",
year = "2002",
month = "8",
day = "30",
doi = "10.1126/science.1073733",
language = "English (US)",
volume = "297",
pages = "1559--1561",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "5586",

}

TY - JOUR

T1 - Medulloblastoma growth inhibition by Hedgehog pathway blockade

AU - Berman, David M.

AU - Karhadkar, Sunil S.

AU - Hallahan, Andrew R.

AU - Pritchard, Joel I.

AU - Eberhart, Charles G

AU - Watkins, D. Neil

AU - Chen, James K.

AU - Cooper, Michael K.

AU - Taipale, Jussi

AU - Olson, James M.

AU - Beachy, Philip A.

PY - 2002/8/30

Y1 - 2002/8/30

N2 - Constitutive Hedgehog (Hh) pathway activity is associated with initiation of neoplasia, but its role in the continued growth of established tumors is unclear. Here, we investigate the therapeutic efficacy of the Hh pathway antagonist cyclopamine in preclinical models of medulloblastoma, the most common malignant brain tumor in children. Cyclopamine treatment of murine medulloblastoma cells blocked proliferation in vitro and induced changes in gene expression consistent with initiation of neuronal differentiation and loss of neuronal stem cell-like character. This compound also caused regression of murine tumor allografts in vivo and induced rapid death of cells from freshly resected human medulloblastomas, but not from other brain tumors, thus establishing a specific role for Hh pathway activity in medulloblastoma growth.

AB - Constitutive Hedgehog (Hh) pathway activity is associated with initiation of neoplasia, but its role in the continued growth of established tumors is unclear. Here, we investigate the therapeutic efficacy of the Hh pathway antagonist cyclopamine in preclinical models of medulloblastoma, the most common malignant brain tumor in children. Cyclopamine treatment of murine medulloblastoma cells blocked proliferation in vitro and induced changes in gene expression consistent with initiation of neuronal differentiation and loss of neuronal stem cell-like character. This compound also caused regression of murine tumor allografts in vivo and induced rapid death of cells from freshly resected human medulloblastomas, but not from other brain tumors, thus establishing a specific role for Hh pathway activity in medulloblastoma growth.

UR - http://www.scopus.com/inward/record.url?scp=0037200078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037200078&partnerID=8YFLogxK

U2 - 10.1126/science.1073733

DO - 10.1126/science.1073733

M3 - Article

C2 - 12202832

AN - SCOPUS:0037200078

VL - 297

SP - 1559

EP - 1561

JO - Science

JF - Science

SN - 0036-8075

IS - 5586

ER -